STMN STRAUMANN HOLDING AG

Invitation to Straumann Group’s FYR 2024 analysts and media conference at Straumann Group Headquarters

Straumann Holding AG / Key word(s): Quarter Results/Sales Result
Invitation to Straumann Group’s FYR 2024 analysts and media conference at Straumann Group Headquarters

27.01.2025 / 15:28 CET/CEST


Date: Wednesday, February 19, 2025

Program:

09:30 a.m. CET Door opening & welcome coffee

10:00 – 11:00 a.m. CET Presentation, questions and answers

Location:

Straumann Group headquarters

Peter Merian-Weg 12

4052 Basel, Switzerland

The Straumann Group Management will review the operational performance of the fiscal year 2024, provide an outlook, and answer questions from investors, financial analysts and journalists. The conference and Q&A session will be held in English.

Please send your response no later than February 14, 2025

Straumann Group

Corporate Communications & Investor Relations

E-Mail:

There will also be a live audio webcast that can be accessed via , and a recording will be available afterwards.

With kind regards

Straumann Group Corporate Communications & Investor Relations



End of Media Release


Language: English
Company: Straumann Holding AG
Peter Merian-Weg 12
4052 Basel
Switzerland
Phone:
Fax: 6
E-mail:
Internet: -group.com
ISIN: CH1175448666
Valor: 914326
Listed: SIX Swiss Exchange
EQS News ID: 2075485

 
End of News EQS News Service

2075485  27.01.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2075485&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
27/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRAUMANN HOLDING AG

Oliver Metzger
  • Oliver Metzger

Straumann Holding AG : Solid dental implant market, no relief in North...

The IDS confirmed our expectations for the dental implant market. North American dynamics are impacted by high interest rates and no short-term relief is expected. However, the mid- to long-term prospects are seen as positive. The valuation multiples already reflect the weakness in North America but the strong prospects for the other regions (72% of sales) are not included. We reiterate our Outperform rating with a reduced target price of CHF150 (from CHF163). Our lower estimates (2025 organic g...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch